Urology
Volume 75, Issue 5 , Pages 1108-1113.e1 , May 2010

The Loss of Radiographic Enhancement in Primary Renal Cell Carcinoma Tumors Following Multitargeted Receptor Tyrosine Kinase Therapy is an Additional Indicator of Response

  • C. Lance Cowey

      Affiliations

    • Division of Hematology and Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
  • ,
  • Julia R. Fielding

      Affiliations

    • Department of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • ,
  • W. Kimryn Rathmell

      Affiliations

    • Division of Hematology and Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
    • Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    • Corresponding Author InformationReprint requests: W. Kimryn Rathmell, M.D., Ph.D., 450 West Drive, CB 7295, Lineberger Cancer Center, Room 21–237, Chapel Hill, NC 27599

Received 20 May 2009 ,Accepted 28 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by the Doris Duke Charitable Foundation (WKR) and the UNC Hematology T32 training grant (CLC).

 Julia R. Fielding and W. Kimryn Rathmell are co-corresponding authors.

PII: S0090-4295(09)02392-9

doi: 10.1016/j.urology.2009.06.105

Urology
Volume 75, Issue 5 , Pages 1108-1113.e1 , May 2010